COVID-19
TOOLBOX
Filter
26
Featured
Language
Document type
Fact sheets
14
Guidelines
6
Studies & Reports
4
Manuals
1
Situation Updates
1
Countries / Regions
West and Central Africa
3
East and Southern Africa
3
India
3
Germany
2
Brazil
2
South Sudan
2
Western and Central Europe
1
South Korea
1
Authors & Publishers
World Health Organization WHO
9
Africa CDC Centres for Disease Control and Prevention
4
African Union
4
European Medicines Agency EMA
3
World Health Organization WHO, et al.
2
and C. Wonodi
1
BBC
1
Gesellschaft für Thrombose-undHämostaseforschung e.V. GTH
1
Greinacher, A., et al.
1
Knoll, M.D.
1
Medicines and Healthcare products Regulatory Agency (MHRA) UK
1
OPAS
1
OPAS, OMS
1
Pan American Health Organisation PAHO
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
World Health Organization WHO, Regional Office of Europe
1
World Health Organization WHO, SAGE
1
Publication Years
Category
COVID-19
12
Guidelines
2
Policies
1
Toolboxes
Vaxzevria (Astra Zeneca)
26
Country specific documents
2
SARS-CoV-2 Variants
2
Pediatrics
1
For Parents & Children
1
Immunization Guidelines
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Covaxin
1
Booster Doses
1
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021 Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc... more
10 February 2021. Draft
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
Manufacturers: SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])] Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)] Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir... more
AstraZeneca-SKBio in South Korea and Serum Institute of India
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages 18 Febr. 2021
7 April 2021
New England Journal of Medicine April 9, 2021 DOI: 10.1056/NEJMoa2104840
7 April 2021 Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed. Available in Englisch, French and Russian
10 May 2021. Manufactureres: SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])] Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)] The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto... more
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp... more
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.